Amazon Web Services (AWS) has detailed how Bluesight developed Prism, an AI layer that connects hospital pharmacy and compliance data across its product suite. The tool is designed to tackle a major pain point for hospitals: the time-consuming process of ensuring compliance with the federal 340B drug pricing program.
The 340B program allows hospitals that serve low-income and uninsured patients to buy outpatient drugs at steep discounts. But to qualify for these discounts, hospitals must prove that their purchases through Group Purchasing Organisations (GPOs) meet strict exception rules. This process is currently done largely by hand.
How Prism Automates 340B Compliance Checks
According to AWS vendor statements, a single 340B covered entity can spend more than 4,000 staff hours each year reviewing whether GPO drug purchases qualify for an exception. Staff must manually compare purchase data with US Food and Drug Administration (FDA) shortage notices and the American Society of Health-System Pharmacists (ASHP) drug shortage list.
Prism Assistant for ControlCheck has reached general availability and is already operating across 20 health systems. The AI automates this comparison, flagging which purchases are eligible for the GPO exception and which are not.
What's Coming Next for Bluesight's AI Suite
Bluesight has also announced a multi-product agent for 340B GPO compliance that remains scheduled for release later in 2026. This agent will work across multiple Bluesight products to provide a unified compliance view.
The project addresses a data-intensive process that hospital pharmacy teams often conduct manually. By using AI built on AWS infrastructure, Bluesight aims to free up pharmacy staff to focus on patient care rather than paperwork.
Our Take: This Is Where AI Makes Real Sense
In our view, this is exactly the kind of problem AI should solve. The 340B program is complex, the rules are strict, and the penalties for non-compliance can be severe. Yet the current process relies on humans cross-referencing multiple government databases — a task that is both tedious and error-prone.
Automating this work does not just save money. It reduces the risk of costly compliance failures and allows pharmacists to spend their time on clinical work. For hospitals already stretched thin, that is a meaningful improvement.
The fact that Prism is already live across 20 health systems suggests Bluesight has built something that works in the real world. If the multi-product agent scheduled for 2026 delivers on its promise, this could become a standard tool for hospital pharmacy compliance.
